跳至主要内容
临床试验/NCT00079469
NCT00079469已完成不适用

Contingency Management to Enhance Smoking Cessation for Cancer Survivors: A Proof of Concept Trial

National Institutes of Health Clinical Center (CC)2 个研究点 分布在 1 个国家开始时间: 2004年2月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
试验地点
2

研究概览

简要总结

RATIONALE: Contingency management is a behavioral treatment approach that provides immediate rewards for positive change in behavior such as quitting smoking. In this protocol, contingency management will be in the form of a cash reward. A smoking cessation (stop-smoking) program that combines contingency management with bupropion and counseling may be effective in helping cancer survivors stop smoking.

PURPOSE: Randomized clinical trial to compare the effectiveness of bupropion and counseling with or without contingency management in helping cancer survivors stop smoking.

详细描述

OBJECTIVES:

Primary

  • Compare the feasibility of a multi-component smoking cessation intervention comprising bupropion and counseling with or without contingency management (cash reward) for cancer survivors who continue to smoke.
  • Compare 7-day point-prevalence abstinence rates in patients treated with these smoking cessation interventions.

Secondary

  • Determine the characteristics of these patients that predict success at quitting smoking.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Prevention

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

研究点 (2)

Loading locations...

相似试验